Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. Santanelli di Pompeo F, Sorotos M, Clemens MW, Paolini G, Anibaldi P, Davoli M, Baglio G, Pinnarelli L, Ferranti M, Cerza F, Cicala SD, Firmani G (2022) Mortality rate in breast implant surgery: is an additional procedure worthwhile to mitigate BIA-ALCL risk?. Aesthet Plast Surg
2. De Jong WH, Panagiotakos D, Proykova A et al (2021) Final opinion on the safety of breast implants in relation to anaplastic large cell lymphoma: report of the scientific committee on health, emerging and environmental risks (SCHEER). Regul Toxicol Pharmacol 125:104982. https://doi.org/10.1016/j.yrtph.2021.104982
3. FDA Questions and answers about BIA-ALCL. https://www.fda.gov/medical-devices/breast-implants/questions-and-answers-about-breast-implant-associated-anaplastic-large-cell-lymphoma-bia-alc. Accessed 17 November 2022.
4. Santanelli di Pompeo F, Clemens MW, Atlan M, Botti G, Cordeiro PG, De Jong D, Di Napoli A, Hammond D, Haymaker CL, Horwitz SM, Hunt K, Lennox P, Mallucci P, Miranda RN, Munhoz AM, Swanson E, Turner SD, Firmani G, Sorotos M (2022) Practice recommendation updates from the world consensus conference on BIA-ALCL. Aesthet Surg J 42(11):1262–1278
5. Mercer N (2022) What is missing from the 2022 practice recommendation updates from the world consensus conference on BIA-ALCL?. Aesthet Surg J. sjac274
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献